local_hospital

Expansion Centres Hemodialyse Ouest

Address
34 Rue De Guetteloup, 72100 Le Mans, France

Cardiovascular and Kidney-Related Research

At Expansion Centres Hemodialyse Ouest in Le Mans, the clinical research focus includes Cardiovascular Diseases alongside reproductive and urinary physiological phenomena, with a strong emphasis on chronic kidney disease and uncontrolled hypertension. The trials are designed to explore better ways to manage blood pressure and reduce serious long-term complications in people with impaired kidney function.

  • Testing a treatment approach aimed at improving blood pressure control in moderate to severe chronic kidney disease
  • Evaluating whether better hypertension management can lower kidney failure, cardiovascular events, and mortality

This work reflects a practical effort to improve everyday care for patients facing both kidney and heart-related risks.

Anticoagulation and Dialysis Care

Another area of research at this site centers on Male Urogenital Diseases and related urinary health concerns, with studies involving patients on chronic peritoneal dialysis who also have non-valvular atrial fibrillation. The main goal is to compare treatments used to prevent clot-related complications while paying close attention to safety.

  • Comparing the safety of two blood-thinning medicines in dialysis patients
  • Assessing the risk of bleeding while supporting treatment choices for atrial fibrillation

The research aims to help clinicians choose therapies that balance effectiveness with a lower risk of harm in a complex patient group.

Site Overview

assignment
1
connected trial
corporate_fare
1
sponsor
science
4
IMPs

Activity Indicator

Last 6 months

0
Trials started
0
Trials started 6–12 months ago
1
Total trials linked
Low Activity
trending_flatStable0%
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status
lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
1
Sponsors (total)
1
Active sponsors
1

Sponsor Network

Top 1 by active trials.

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

No repeated partnerships found.

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 978 other sites in France

description
Trial volume
1
Outperforms 2% of sites
public
Therapeutic diversity
2areas
Outperforms 40% of sites
groups
Sponsor diversity
1sponsors
Outperforms 2% of sites

Therapeutic Area Benchmark — France

Select a therapeutic area to compare against other sites in France.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: France

Market Share

Country: France

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Expansion Centres Hemodialyse Ouest

Trial Sponsor Phase Status Start Date End Date
THINK - intensification of blood pressure lowering Therapeutics based on diuretics versus usual management for uncontrolled Hypertension IN patients with moderate to severe chronic Kidney disease: an open label, cluster randomized controlled, phase 3 trialCentre Hospitalier Regional Universitaire De ToursPhase IIIRecruitingMar 2023

IMP list

lock Showing 1 of 4 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Amiloride Hydrochloride1Unknown2023-03-282023-03-28

Request feasibility information

Ask this centre about capacity, equipment and patient population.

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.